The global antisense oligonucleotides market size is expected to generate US$ 5,659.2 million in revenue by 2032, up from US$ 1,921.6 million in 2022, with a CAGR of 10.3% over the forecast period.
The fact that antisense oligonucleotides offer promising therapy options for a variety of medical illnesses influences their adoption trends greatly. Furthermore, they permit the creation of therapies that affect protein targets that cannot be treated with protein therapeutics, hence accelerating market growth. They can target a specific faulty gene, interfere with RNA activity at the cellular level, and can also be silenced or manipulated, which has piqued the interest of market participants.
Get Sample Report + Related Graphs & Charts@ https://www.futuremarketinsights.com/reports/sample/rep-gb-5377
The increasing demand for antisense oligonucleotides can be linked to their assistance in changing the immune system, which facilitates the treatment of a wide range of autoimmune illnesses that are not treatable with currently available medications.
Key Takeaways
- Due to a strong product pipeline and an increasing number of FDA approvals in the area, North America clearly dominates the worldwide antisense oligonucleotides market, accounting for 56% of the market in 2022.
- In 2022, Europe’s antisense oligonucleotide market is expected to account for 10.0% of the total.
Growth Drivers
A robust pipeline of antisense oligonucleotides, as well as greater emphasis on a high number of product approvals and commercialization, are expected to drive growth in the worldwide antisense oligonucleotides market.
Furthermore, substantial breakthroughs in the realm of antisense oligonucleotides at the therapeutic or clinical level are fueling the worldwide antisense oligonucleotides market.
However, the worldwide antisense oligonucleotide market is facing various obstacles relating to oligonucleotide diversity, delivery, and regulatory complexity.
Contact Us for a Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-5377
Key Players
- Ionis Pharmaceuticals, Inc.
- Sarepta Therapeutics
- Biogen
- Alnylam Pharmaceuticals, Inc.
- Antisense Therapeutics Limited
- Isarna Therapeutics GmbH
- Arrowhead Pharmaceuticals, Inc.
- Alantic Pharmaceuticals, Inc
- Others
Recent Development
- MilliporeSigma (USA) (CDMO) has acquired AmpTec, a well-known German company that specialises in mRNA contract development and manufacturing.
- Integrated DNA Technology (USA) introduced oligo pools, a collection of 350-nucleotide-long, high-quality DNA oligonucleotides.
Key Segments Profiled in the Antisense Oligonucleotides Market Survey
By Drug:
- Approved Drugs
- Pegaptanib
- Mipomersen
- Eteplirsen
- Pipeline Analysis
By Indication:
- Ocular Diseases
- Cancer
- Diabetes
- Amyotrophic Lateral Sclerosis (ALS)
- Duchenne Muscular Dystrophy
- Spinal Muscular Atrophy
- Others
By Application:
- Basic Research
- Genomics
- Target Validation
- Drug Discovery
Request Customization of Report@ https://www.futuremarketinsights.com/customization-available/rep-gb-5377
What key insights does the Antisense Oligonucleotides market research provide?
- Historical and current year revenue of related Antisense Oligonucleotides market players analyzed at the regional level.
- One by one company profile of prominent stakeholders.
- Analysis of the Antisense Oligonucleotides market size on the basis of product type and end-use type.
- Accurate Antisense Oligonucleotides market forecast in terms of value and volume in numbers and percentages.
- Demand prospect of each segment covered in the report.
The Antisense Oligonucleotides market research gets rid of the following queries:
- How the market for Antisense Oligonucleotidess is expected to shape in the coming ten years?
- What strategies are the Antisense Oligonucleotides market vendors implementing to stay ahead of their rivals?
- Why are consumers shifting towards alternative Antisense Oligonucleotides products?
- What innovative technologies are the Antisense Oligonucleotides players using to get an edge over their rivals?
- What are the restraints affecting the growth of the global Antisense Oligonucleotides market?
Why choose Future Market Insights?
- Modern technologies, such as artificial intelligence, to provide updated industry trends.
- Data collection from implementation vendors, service providers, and raw material suppliers to provide a clear perspective.
- Interaction with research scientists and development heads to understand the nature of the market more precisely.
- Three-step quality check process – Data collection, triangulation, and validation.
- 24/7 availability of services.
About Future Market Insights, Inc.
Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs
